LSX are known for bringing life science investors together to assess and meet with the most promising up-and-coming biotech companies. When the first mRNA vaccines hit the market in 2020, one of our investors asked us to look at the resurgence of therapeutics targeting or made of RNA with the view to developing a high-level conference. And so, RNA Leaders was born.The 2022 RNA Leaders Series saw 100+ world-class speakers and over 600+ senior leaders from around the world join the most comprehensive and only RNA industry-focused events in Europe (Basel) in the spring and the US (Boston) in the fall.